Cervical cancer is still the most common gynecological malignancy in China. Treatment of patients with early stage cervical cancer has been quite successful, but there are still patients with middle and late stage who will recur, metastasize, or even die. The primary purpose of follow-up is to detect recurrent disease at an early stage, thereby improving clinical outcomes through early diagnosis and treatment. Routinely used postoperative follow-up tools are 1. use of vaginal dissection smear + vaginal dissection HPV test and colposcopy + biopsy if necessary 2. evaluation of tumor markers such as squamous cell carcinoma antigens may be of interest. 3. Imaging techniques are important for monitoring and evaluating recurrent disease. Regular chest x-ray is still controversial in monitoring asymptomatic recurrence in patients after treatment for cervical cancer. More recommended lung CT routinely are ultrasound of the liver, gallbladder, pancreas, spleen, both kidneys, both ureters and bladder, pelvic ultrasound (gynecology), X-ray tomography (CT) and magnetic resonance imaging (MRI) when neoplastic abnormal masses appear due to cancer growth or for monitoring the extent of known lesions. fluoro-2-deoxy-glucoseYpositron emission tomography (PET-CT) has only 80% specificity and accuracy (100% negative predictive value) for the surveillance of recurrent cervical cancer. negative predictive value). Combined PET/CT examination provides precise anatomical localization of suspicious areas.